Ayro Inc SEC Filings

StableX Technologies' proxy excerpts show shareholder ownership details and securities that may convert into common stock. There were 888,978 shares of common stock outstanding on the record date and 50 shares of Series H-6 preferred outstanding. Iroquois-related holders led with 94,850 shares (reported as 9.99% beneficial ownership), followed by The Hewlett Fund with 46,689 shares (4.99%) and Mainfield Enterprises with 44,567 shares (4.99%). The filing discloses multiple convertible preferred holdings and warrants exercisable within 60 days of the record date (each subject to a 9.99% or 4.99% beneficial ownership blocker), which could increase common shares if converted or exercised subject to approvals and ownership limits.

Ayro, Inc.'s preliminary proxy filing discloses beneficial ownership details for common stock and certain preferred/warrant positions. The record shows 888,978 shares of common stock outstanding. Iroquois-related holders led by Richard Abbe/Iroquois Capital report 94,850 shares, representing 9.99% beneficial ownership when combining common shares, convertible preferred interests and warrants subject to a 9.99% ownership blocker. The Hewlett Fund holds 46,689 shares (4.99%) and Mainfield Enterprises holds 44,567 shares (4.99%), each with convertible preferred and warrant positions noted. Several executives and directors hold modest common and restricted stock unit positions. The filing explicitly notes conversion features, warrant exercisability within 60 days of the record date, and beneficial ownership blockers limiting conversions.

Signatures on the amendment include Joshua Silverman as Executive Chairman and Thomas M. Wittenschlaeger as CEO on behalf of Ayro and related parties.

AYRO, Inc. filed a Form D reporting a Regulation D offering under Rule 506(b). The notice states the total offering amount was $7,000,000, the total amount sold was $7,000,000, and $0 remains to be sold. The issuer reports 10 investors have invested to date and identifies the first sale date as 2025-08-08. Sales commissions are reported as $560,000 (listed as an estimate) and the issuer issued placement-agent warrants to purchase up to 140,000 shares at an $8.00 exercise price (subject to adjustment). The filing lists AYRO's principal address in New York and names Joshua Silverman as CEO, Joseph Ramelli as CFO and several directors and officers.

AYRO, Inc. Schedule 13G/A discloses beneficial ownership positions reported by Iroquois Capital Management, LLC and two associated individuals, Richard Abbe and Kimberly Page. The filing shows Iroquois beneficially holds 179,450 shares (reported as 9.99% of the class), Mr. Abbe aggregates 507,899 shares (9.99%), and Ms. Page aggregates 507,899 shares (9.99%), with reported voting and dispositive power details for each party.

The reported totals include a combined 499,634 shares of common stock issuable upon conversion of preferred stock; those conversions are explicitly stated to be subject to a 9.99% blocker. The percentage calculations reference an estimated 543,217 shares outstanding used to compute the 9.99% figures. The filing also explains overlapping authorities between the reporting persons and clarifies that such statements are not admissions of beneficial ownership of other reporting persons' shares.

AYRO, Inc. entered into a Securities Purchase Agreement to issue a newly designated Series I Convertible Preferred Stock and related warrants to certain accredited investors. The Company agreed to sell an aggregate of 7,000 shares of Series I Preferred Stock with a stated value of $1,000 per share, initially convertible into up to 875,000 shares of common stock at an initial conversion price of $8.00 per share. The transaction also includes warrants to acquire up to an aggregate of 875,000 shares of common stock at an exercise price of $8.00 per share. The Company filed the Certificate of Designations creating the Series I Preferred Stock.

The Company also filed an amendment to its Series H-7 Certificate of Designations that, as disclosed, extends the maturity date to February 4, 2027, revises payment dates and payable amounts for dividends and installment amounts, modifies the definition of "Excluded Securities," and adjusts the schedule of installment dates. Series H-7 holders provided waivers and consents and the Company filed the related Certificate of Amendment. These actions change certain security rights and provide for the issuance of the Series I securities referenced above.